Condition
Function of Renal Transplant
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01095172Phase 4UnknownPrimary
RituxiMab INDuction in Renal Transplantation
NCT01759862Not ApplicableCompletedPrimary
Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant
NCT01292525Phase 3TerminatedPrimary
Protocol Calcineurin Inhibitor (CNI) Weaning
NCT01443013CompletedPrimary
Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
NCT00223054CompletedPrimary
Polymorphism of the Cytochrome P450-system in Renal Transplants
Showing all 5 trials